URMC / Research / Clinical Trials / Study Details

PLEU15048 / ACCL1333 / CV185-155 / Angela Girvin

Research Question:
Does the drug Apixaban prevent blood clots in children with leukemia or lymphoma?

Basic Study Information

Purpose:
The purpose of this study is to compare the effect of a blood thinning drug called Apixaban versus no administration of a blood thinning drug, in preventing blood clots in children with leukemia or lymphoma. Patients must be receiving chemotherapy, including asparaginase, and have a central line (a catheter inserted for administration of medications and blood sampling)

Location: University Of Rochester General Clinical Research Center

Lead Researcher (Principal Investigator)

Lead Researcher: Angela Girvin

Study Contact Information

Study Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Email: tina_bowdish@urmc.rochester.edu

Additional Study Details

Contact This Study

First Name *

This field is required

Middle Name

Last Name *

This field is required

Phone Number

I agree to be contacted by The University of Rochester Medical Center regarding participation in this study. *

You must agree to be contacted to continue.

Please call me during the day.

Please call me during the evening.

Message

Return to Search

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Wilmot Research